KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K Filing

Kestra Medical Technologies reported Q1 FY2027 revenue of $31.0M, up 60% YoY with gross margin expansion to 56.5% (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $KMTS

Read the full article at SEC EDGAR

More Regulatory news